Schmidlen Tara, Sturm Amy C, Hovick Shelly, Scheinfeldt Laura, Scott Roberts J, Morr Lindsey, McElroy Joseph, Toland Amanda E, Christman Michael, O'Daniel Julianne M, Gordon Erynn S, Bernhardt Barbara A, Ormond Kelly E, Sweet Kevin
Genomic Medicine Institute, Geisinger Health System, Danville, PA, USA.
Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ, 08103, USA.
J Genet Couns. 2018 Sep;27(5):1111-1129. doi: 10.1007/s10897-018-0230-z. Epub 2018 Feb 19.
With the advent of widespread genomic testing for diagnostic indications and disease risk assessment, there is increased need to optimize genetic counseling services to support the scalable delivery of precision medicine. Here, we describe how we operationalized the reciprocal engagement model of genetic counseling practice to develop a framework of counseling components and strategies for the delivery of genomic results. This framework was constructed based upon qualitative research with patients receiving genomic counseling following online receipt of potentially actionable complex disease and pharmacogenomics reports. Consultation with a transdisciplinary group of investigators, including practicing genetic counselors, was sought to ensure broad scope and applicability of these strategies for use with any large-scale genomic testing effort. We preserve the provision of pre-test education and informed consent as established in Mendelian/single-gene disease genetic counseling practice. Following receipt of genomic results, patients are afforded the opportunity to tailor the counseling agenda by selecting the specific test results they wish to discuss, specifying questions for discussion, and indicating their preference for counseling modality. The genetic counselor uses these patient preferences to set the genomic counseling session and to personalize result communication and risk reduction recommendations. Tailored visual aids and result summary reports divide areas of risk (genetic variant, family history, lifestyle) for each disease to facilitate discussion of multiple disease risks. Post-counseling, session summary reports are actively routed to both the patient and their physician team to encourage review and follow-up. Given the breadth of genomic information potentially resulting from genomic testing, this framework is put forth as a starting point to meet the need for scalable genetic counseling services in the delivery of precision medicine.
随着用于诊断指征和疾病风险评估的广泛基因组检测的出现,优化遗传咨询服务以支持精准医学的可扩展交付的需求日益增加。在此,我们描述了我们如何实施遗传咨询实践的双向参与模型,以制定一个咨询组件框架和用于传达基因组结果的策略。该框架是基于对在网上收到潜在可操作的复杂疾病和药物基因组学报告后接受基因组咨询的患者进行的定性研究构建的。我们寻求与包括执业遗传咨询师在内的跨学科研究团队进行磋商,以确保这些策略具有广泛的范围和适用性,可用于任何大规模基因组检测工作。我们保留了孟德尔/单基因疾病遗传咨询实践中确立的检测前教育和知情同意的提供。在收到基因组结果后,患者有机会通过选择他们希望讨论的特定检测结果、指定讨论问题以及表明他们对咨询方式的偏好来调整咨询议程。遗传咨询师利用这些患者偏好来安排基因组咨询会议,并对结果沟通和降低风险建议进行个性化。量身定制的视觉辅助工具和结果总结报告将每种疾病的风险领域(基因变异、家族史、生活方式)进行划分,以促进对多种疾病风险的讨论。咨询后,会议总结报告将主动发送给患者及其医生团队,以鼓励他们进行审查和跟进。鉴于基因组检测可能产生的基因组信息范围广泛,该框架被提出作为满足精准医学交付中可扩展遗传咨询服务需求的起点。